Chs (CHSCN) EBITDA (2010 - 2026)

Chs has disclosed EBITDA across 17 years of filings, most recently posting -$241.8 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$241.8 million, down 40.61% year-over-year; the trailing twelve-month figure through Feb 2026 was $4.3 million (down 95.18% YoY), and the FY2025 annual result was $90.8 million, down 84.47% from the prior year.
• EBITDA came in at -$241.8 million for Q1 2026 at Chs, down from $121.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $644.5 million in Q4 2022 to a low of -$241.8 million in Q1 2026.
• The 5-year median for EBITDA is $137.8 million (2024), against an average of $159.5 million.
• Across the five-year window, EBITDA surged 476.91% in 2023 and sank 354.14% in 2025, its largest moves.
• Chs' EBITDA stood at $644.5 million in 2022, then tumbled by 39.04% to $392.9 million in 2023, then slumped by 64.92% to $137.8 million in 2024, then retreated by 12.04% to $121.2 million in 2025, then slumped by 299.44% to -$241.8 million in 2026.
• The last three EBITDA figures came in at -$241.8 million (Q1 2026), $121.2 million (Q4 2025), and $53.9 million (Q3 2025), per Business Quant data.